Results 241 to 250 of about 50,155,014 (329)

Editorial Team

Drug Analytical Research, 2020
Drug Analytical Research
doaj  

Addressing the Challenges of Traditional, Complementary, and Integrative Medicine Research: An International Perspective and Proposed Strategies Moving Forward

Maheen Raja, Holger Cramer, Myeong Soo Lee, L. Susan Wieland, Jeremy Y. Ng   +4 more
openalex   +1 more source

Policy enactment, context and performativity: ontological politics and researching Australian National Partnership policies

, 2014
Parlo Singh, Stephen Heimans, Kathryn Glasswell   +2 more
openalex   +2 more sources

Exploring within and between associations of momentary mindfulness and emotion regulation and the moderating effects of mental health among adolescents. [PDF]

J Res Adolesc
Miller-Chagnon RL, Prince MA, Haddock SA, Zimmerman TS.   +3 more
europepmc   +1 more source

Ukraine-NATO: \uabInvite us\ubb\u2026? [PDF]

, 2002
Research, Update
core  

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Precincts and Prospects in the Use of Focus Groups in Social and Behavioral Science Research

, 2015
Dominic Sagoe
openalex   +2 more sources

Developing and Testing Electronic Versions of the Advance QoL Tools for Collecting Self-Reports of Quality of Life in Children and Adolescents With Advanced Cancer. [PDF]

Scand J Caring Sci
Robichaud LA, Guarascio N, Duval M, Michon B, Olivier-D'Avignon M, Tyo-Gomez M, Rondeau É, Marquis MA, Sultan S.   +8 more
europepmc   +1 more source

2002 election campaign: summing up [PDF]

, 2002
Research, Update
core  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source